SINGAPORE, Oct. 6, 2015 (GLOBE NEWSWIRE) -- Zecotek Photonics Inc. (TSX-V:ZMS) (Frankfurt:W1I.F) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that the U.S. Patent office has issued a Notice of Allowance for a novel micro-pixel avalanche photo transistor (MAPT). Zecotek`s scientific team has refined the design of its solid-state micro-pixel avalanche photo diode (MAPD) into a silicon photomultiplier transistor tailored specifically for positron emission tomography (PET) medical imaging and other major sensor industries.
"The patent covering our new micro-pixel avalanche photo transistor includes a superior technological solution to all competing silicon based photomultipliers," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. "The MAPT was a natural next step from our solid-state MAPD photo detectors and other silicon photo detectors, focused to overcome the limitations of the earlier technology and greatly improve the parameters of our photo detectors. Our new MAPT technology is the basis of a much faster photo response, very low capacitance, and higher signal gain due to active individual cells of a photo detector. In some ways, the progress with solid-state photo detectors is similar to the radical improvement of LCD display quality due to the shift from passive-matrix technology to TFT displays. As leading organizations, in the imaging and sensor industries and high energy physics, redefine their designs by adopting more advanced silicon photomultipliers, Zecotek will continue its leading role in the world of photonics by creating new and improved imaging technologies."
The newly designed MAPT is positioned to become the leading photo sensor in areas of time-of-flight optical photo detection. The MAPT technology allows at least 10 times shorter photo-response duration with 10 times as high photo-response signal in comparison to known analogues. Although speed is of special importance in such critical applications as time-of-flight PET, high-energy physics, and optical ranging detectors, the improved parameters will also broaden the number of applications by allowing higher gains typical of photomultiplier tubes and large-area photo-detectors. A significant market for this technology is automobile sensors, because the MAPT operates in all the regions of light sensitivity (ultraviolet, visible and infrared), and automobile sensors use infrared. Furthermore, the MAPT technology is not specific to the base semiconductor material, thus opening the prospect of expanding the available detection spectrum to UV and IR optical ranges by using suitable materials such as gallium nitride or germanium.
Zecotek Photonics Inc (TSX-V:ZMS) (Frankfurt:W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, 3D metal printing, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Optronics Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners including Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea). For more information visit www.zecotek.com, follow @zecotek on Twitter and "like" us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
CONTACT: For Additional Information Please Contact: Zecotek Photonics Inc. Michael Minder T: (604) 783-8291 firstname.lastname@example.orgSource:Zecotek Photonics Inc.